Clinical studies recruiting near Sarasota

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · Florida Cancer Specalists · Erasca, Inc. · NCT06983743 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · CAN Community Health ( Site 1510) · Merck Sharp & Dohme LLC · NCT07266831 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · First Physicians Group /ID# 272180 · AbbVie · NCT06682988 A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced
Phase 1 · Florida Cancer Specialists - Sarasota · Kumquat Biosciences Inc. · NCT06994806 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Intercoastal Medical Group · Amgen · NCT07037433 A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · CAN Community Health Inc. · Gilead Sciences · NCT07645287 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Covenant Metabolic Specialists, LLC · Gilead Sciences · NCT06051617 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Florida Cancer Specialists · Artios Pharma Ltd · NCT04657068 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Florida Cancer Specialists - Sarasota · NRG Oncology · NCT06532279 A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Phase 2 · Gulfcoast Research Institute · Pacira Pharmaceuticals, Inc · NCT06884865 Study of AVZO-021 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Florida Cancer Specialists · Avenzo Therapeutics, Inc. · NCT05867251 Preventing Alzheimer's With Cognitive Training
Phase 3 · The Roskamp Institute · University of South Florida · NCT03848312 Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Phase 2 · Site 123 · Yarrow Bioscience, Inc. · NCT07682896 A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Phase 1 · Florida Cancer Specialists - Sarasota · Compass Therapeutics · NCT06150664 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · Florida Cancer Specialists · BioNTech SE · NCT07070232 A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Phase 1 · Florida Cancer Specialists · Janssen Research & Development, LLC · NCT05818683 Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Phase 1 · Zai Lab Site 02026 · Zai Lab (Shanghai) Co., Ltd. · NCT07374848 CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Clinical Study Site · Crescent Biopharma, Inc. · NCT07335497 AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metasta
Phase 1/Phase 2 · Avenzo Therapeutics Recruiting Site · Avenzo Therapeutics, Inc. · NCT07038343 A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Sarasota Clinical Research · Uniquity One (UNI) · NCT06496620 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C M
Phase 1/Phase 2 · Florida Cancer Specialists · Revolution Medicines, Inc. · NCT06128551 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · Florida Cancer Specialists - Sarasota Downtown · Canadian Cancer Trials Group · NCT05640999 Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · Intercoastal Medical Group, Inc. · GAP Innovations, PBC · NCT06584357 First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Incl
Phase 1 · Florida Cancer Specialists · Accent Therapeutics · NCT06799065 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Florida Cancer Specialists - Sarasota Downtown · National Cancer Institute (NCI) · NCT05256225 A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Phase 1 · Florida Cancer Specialists · Conjupro Biotherapeutics, Inc. · NCT05948865 Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Phase 1 · Florida Cancer Specialists & Research Institute (FCS) - Sara · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT06384352 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Florida Cancer Specialists · Pfizer · NCT07222800 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Florida Cancer Specialists - Sarasota · NRG Oncology · NCT04852887

Look up another city

Look up another condition